MedTrace Logo

Immunosuppressants to Postoperative Infection and Death

NCT06121804 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2023-11-08

No results posted yet for this study

Summary

The goal of this observational study is to explore the different immunosuppressive agents and related outcomes in organ transplantation patients in Taiwan. The main question it aims to answer is the risk of different immunosuppressive agents for infection and survival after transplant.

The study enrolled patients who underwent solid organ transplant (SOT), kidney (ICD-9-CM code V42.0), liver (ICD-9-CM code V42.7), or lung (ICD-9-CM code V42.6) transplants. We employed propensity score matching (PSM) to establish a matched cohort. The study will compare SOT patients and general patients to explore the risk of different immunosuppressive agents for infection and survival.

Conditions

  • Organ Transplantation
  • Immunosuppressive Agents
  • Cohort Study

Interventions

DRUG

Immunosuppressive Agents

Prescribing immunosuppressive agents

Sponsors & Collaborators

  • Chung Shan Medical University

    lead OTHER

Principal Investigators

  • Chien-Ying Lee, PhD · Chung Shan Medical University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-20
Primary Completion
2024-11-20
Completion
2024-12-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121804 on ClinicalTrials.gov